Prospera Financial Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$804K Sell
3,238
-6,331
-66% -$1.36M 0.01% 864
2026
Q1
$1.92M Buy
9,569
+827
+9% +$171K 0.03% 515
2025
Q4
$1.81M Sell
8,742
-567
-6% -$113K 0.03% 501
2025
Q3
$1.67M Buy
9,309
+632
+7% +$108K 0.03% 523
2025
Q2
$1.4M Sell
8,677
-1,381
-14% -$220K 0.03% 559
2025
Q1
$1.71M Sell
10,058
-182
-2% -$31.6K 0.04% 421
2024
Q4
$1.7M Sell
10,240
-11
-0.1% -$1.88K 0.04% 399
2024
Q3
$1.76M Buy
10,251
+5,118
+100% +$847K 0.05% 359
2024
Q2
$790K Sell
5,133
-1,208
-19% -$181K 0.02% 568
2024
Q1
$975K Sell
6,341
-651
-9% -$99.3K 0.03% 498
2023
Q4
$1.11M Sell
6,992
-27,705
-80% -$3.98M 0.04% 441
2023
Q3
$5.08M Sell
34,697
-2,763
-7% -$421K 0.2% 118
2023
Q2
$5.74M Sell
37,460
-1,086
-3% -$169K 0.22% 112
2023
Q1
$5.98M Buy
38,546
+29,438
+323% +$4.62M 0.25% 102
2022
Q4
$1.4M Buy
9,108
+428
+5% +$63.1K 0.07% 287
2022
Q3
$1.15M Buy
8,680
+1,175
+16% +$165K 0.06% 338
2022
Q2
$1.02M Sell
7,505
-1,002
-12% -$138K 0.05% 369
2022
Q1
$1.27M Sell
8,507
-7,924
-48% -$1.17M 0.05% 369
2021
Q4
$2.66M Buy
16,431
+6,941
+73% +$1.12M 0.12% 213
2021
Q3
$1.58M Buy
9,490
+254
+3% +$43.4K 0.08% 288
2021
Q2
$1.59M Sell
9,236
-27,086
-75% -$4.47M 0.08% 279
2021
Q1
$5.83M Buy
36,322
+27,870
+330% +$4.77M 0.35% 49
2020
Q4
$1.42M Buy
8,452
+6,917
+451% +$1.12M 0.1% 231
2020
Q3
$241K Sell
1,535
-1,504
-49% -$246K 0.09% 194
2020
Q2
$510K Sell
3,039
-560
-16% -$87.9K 0.05% 347
2020
Q1
$472K Sell
3,599
-30
-0.8% -$4.27K 0.05% 311
2019
Q4
$540K Hold
3,629
0.04% 371
2019
Q3
$449K Sell
3,629
-2,073
-36% -$276K 0.05% 330
2019
Q2
$803K Buy
5,702
+73
+1% +$10.1K 0.09% 196
2019
Q1
$866K Buy
5,629
+860
+18% +$124K 0.29% 100
2018
Q4
$597K Sell
4,769
-2,007
-30% -$274K 0.12% 167
2018
Q3
$1M Buy
6,776
+3,256
+93% +$493K 0.19% 127
2018
Q2
$495K Buy
3,520
+722
+26% +$99.1K 0.07% 233
2018
Q1
$372K Buy
+2,798
New +$382K 0.05% 295
2017
Q4
Sell
-2,575
Closed -$320K 409
2017
Q3
$320K Sell
2,575
-176
-6% -$20.8K 0.05% 310
2017
Q2
$314K Sell
2,751
-156
-5% -$16.8K 0.05% 299
2017
Q1
$305K Sell
2,907
-1,858
-39% -$186K 0.06% 265
2016
Q4
$435K Sell
4,765
-1,429
-23% -$134K 0.09% 210
2016
Q3
$618K Buy
6,194
+3,331
+116% +$327K 0.12% 148
2016
Q2
$256K Sell
2,863
-732
-20% -$67.2K 0.05% 274
2016
Q1
$315K Buy
3,595
+148
+4% +$13K 0.07% 209
2015
Q4
$390K Buy
3,447
+238
+7% +$25.6K 0.09% 157
2015
Q3
$325K Buy
3,209
+889
+38% +$106K 0.08% 174
2015
Q2
$288K Sell
2,320
-282
-11% -$34K 0.07% 207
2015
Q1
$308K Sell
2,602
-1,444
-36% -$163K 0.07% 214
2014
Q4
$413K Sell
4,046
-435
-10% -$42.5K 0.1% 156
2014
Q3
$212K Buy
4,481
+1,931
+76% +$168K 0.06% 254
2014
Q2
$210K Buy
+2,550
New +$195K 0.06% 250
2014
Q1
Sell
-43,344
Closed -$3M 267
2013
Q4
$3M Buy
43,344
+11,994
+38% +$787K 1.01% 26
2013
Q3
$2.07M Buy
31,350
+12,783
+69% +$809K 0.79% 33
2013
Q2
$1.11M Buy
+18,567
New +$1.06M 0.51% 48

Other funds holding FBT

Prospera Financial Services's FBT Position: Q2 2026 in Review

Prospera Financial Services reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 66% in Q2 2026, selling an estimated $1.36M and leaving 3,238 shares worth $804K. The position accounts for 0.01% of the portfolio, ranked #864.

Prospera Financial Services first reported a position in FBT in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.98M in Q1 2023. 63 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Prospera Financial Services held 3,238 shares of First Trust NYSE Arca Biotechnology Index Fund worth $804K as of Q2 2026.
  • Prospera Financial Services sold 6,331 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $1.36M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Prospera Financial Services's portfolio in Q2 2026, its #864 holding.
  • Prospera Financial Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 51 quarters since.
  • Prospera Financial Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $5.98M in Q1 2023.
  • 63 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.